AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TÉMOZOLOMIDE
11 registrations across 1 African market— 0 active
Markets with TÉMOZOLOMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TEMOZOLOMIDE NEAPOLIS Gélule / 100 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2022 |
| TEMOZOLOMIDE NEAPOLIS Gélule / 250 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2022 |
| TEMOZOLOMIDE NEAPOLIS Gélule / 20 mg | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Sept 2022 |
| TEMO Gélule / 20 mg | 🇹🇳Tunisia | LINO PHARMA | expired | Sept 2021 |
| TEMO Gélule / 5 mg | 🇹🇳Tunisia | LINO PHARMA | expired | Sept 2021 |
| TEMO Gélule / 250 mg | 🇹🇳Tunisia | LINO PHARMA | expired | Sept 2021 |
| TEMO Gélule / 100 mg | 🇹🇳Tunisia | LINO PHARMA | expired | Sept 2021 |
| TEGOZOL Gélule / 20 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Mar 2020 |
| TEGOZOL Gélule / 5 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Mar 2020 |
| TEGOZOL Gélule / 100 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Mar 2020 |
| TEGOZOL Gélule / 250 mg | 🇹🇳Tunisia | HIKMA Pharmaceuticals | expired | Apr 2017 |
TÉMOZOLOMIDE in Africa — Regulatory Overview
TÉMOZOLOMIDE is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 0 (0%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.